Navigation Links
UT Southwestern patient first in North Texas to receive newest-generation heart failure device
Date:10/26/2009

DALLAS Oct. 27, 2009 UT Southwestern Medical Center patient Michael LeBlanc, 40, is the first in North Texas to receive the newest generation of a mechanical device designed to improve heart function. It will be his lifeline while he awaits a heart transplant.

Called a left-ventricular assist device (LVAD), its purpose is to help a patient's weakened heart pump blood throughout the body. For Mr. LeBlanc, it will help his ailing heart continue to pump until the Irving resident receives a new heart. UT Southwestern is the only medical facility in North Texas implanting the HeartWare Ventricular Assist System as part of a national clinical trial testing the effectiveness of the device.

The HeartWare Ventricular Assist System is a little smaller than a hockey puck and two and half times smaller than the earliest versions of LVADs.

Mr. LeBlanc, a Chicago native, moved to the Dallas area 11 years ago in search of new job opportunities. The normal trajectory of his daily life veered wildly when a simple episode of fainting resulted in a life-changing diagnosis: heart failure.

"I kept getting weaker and weaker," he said. "I was blacking out for no reason. I hadn't been sick and have never been a sickly person."

Occasionally, viruses can attack the heart and leave it severely damaged, but people may not know until months or years later. Mr. LeBlanc's doctors theorized he may have had such a virus that ultimately led to heart failure.

"My energy level was up and down. To keep me going, I qualified for a defibrillator, which basically shocked me if my heart rhythm started to get worse," Mr. LeBlanc said. "But as I got sicker, the defibrillator kept going off, and it was awful."

Even with the defibrillator, Mr. LeBlanc suffered a heart attack in April, followed by a stroke in July. Luckily, he was able to get to an emergency room before the stroke did too much damage. After several more weeks in and out of hospitals, Mr. LeBlanc was referred to UT Southwestern University Hospital St. Paul, where he met with cardiologists and cardiothoracic surgeons who determined he would be a good candidate for the new LVAD.

"Mr. LeBlanc has cardiomyopathy, which causes the heart to dilate. The muscle becomes weaker, and it can't pump efficiently," said Dr. Dan Meyer, professor of cardiovascular and thoracic surgery at UT Southwestern and Mr. LeBlanc's surgeon. "UT Southwestern has always had a presence in studying new mechanical assist devices, so we were honored to be only one of two sites in the state selected to implant the HeartWare LVAD as part of a national clinical trial."

The pump is designed to rest inside the patient's chest. A small cable attached to the device exits the body and connects to an externally worn controller. The controller is powered by a battery pack. The HeartWare LVAD has only one moving part, which contributes to its diminutive size. The lack of mechanical bearings is expected to lead both to longer-term device reliability and to a reduced risk of physical damage to blood cells as they pass through the pump, said Dr. Meyer, also director of the mechanical support program at UT Southwestern.

"The size of the device means the incision is also smaller. The entire implantation surgery takes about four hours," Dr. Meyer said. "Mr. LeBlanc is a really great patient. He's otherwise very healthy, and we believe he will do very well with the LVAD until he can get a new heart."

Only a few days after his surgery to implant the device, Mr. LeBlanc said he was feeling much better and he hopes for a quick return to his daily routine. He's still adjusting to some of the stranger side effects of his new device, including no pulse. The LVAD keeps blood moving continually with no pulsation, so he no longer has a palpable heart beat or traditionally measurable blood pressure.

"I'm very happy to have this LVAD, and I think I'll adjust to it fast. I'm just ready to get on with my life," Mr. LeBlanc said. "I've been through everything, and I hope this is the last step I need to take before transplant surgery."


'/>"/>

Contact: Katherine Morales
katherine.morales@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert

Related biology news :

1. Ice cream may target the brain before your hips, UT Southwestern study suggests
2. UT Southwestern researchers examine mechanisms that help cancer cells proliferate
3. UT Southwestern researchers probe kidney damage, protection in lupus
4. Diabetics on high-fiber diets might need extra calcium, report UT Southwestern researchers
5. Two UT Southwestern researchers awarded Sloan fellowships
6. UT Southwestern researchers identify molecule that helps the sleep-deprived to mentally rebound
7. UT Southwestern researchers disrupt biochemical system involved in cancer, degenerative disease
8. Natural brain substance blocks weight gain in mice, UT Southwestern researchers discover
9. UT Southwestern scientist honored among best in Texas research
10. UT Southwestern researchers identify gene linked to inherited form of fatal lung disease
11. Deranged calcium signaling contributes to neurological disorder, UT Southwestern researchers find
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2016)... DUBLIN , April 27, 2016 ... of the  "Global Multi-modal Biometrics Market 2016-2020"  report ... ) , The analysts forecast ... a CAGR of 15.49% during the period 2016-2020.  ... a number of sectors such as the healthcare, ...
(Date:4/13/2016)... -- IMPOWER physicians supporting Medicaid patients in Central ... in telehealth thanks to a new partnership with higi. ... patients can routinely track key health measurements, such as ... when they opt in, share them with IMPOWER clinicians ... retail location at no cost. By leveraging this data, ...
(Date:3/22/2016)... PUNE, India , March 22, 2016 ... new market research report "Electronic Sensors Market for ... Fingerprint, Proximity, & Others), Application (Communication & ... and Geography - Global Forecast to 2022", ... consumer industry is expected to reach USD ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader ... “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, ... providing practical tips, tools, and strategies for clinical researchers. , “The landscape of ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... -- A person commits a crime, and the detective uses ... criminal down. An outbreak of foodborne illness makes ... uses DNA evidence to track down the bacteria that caused ... not. The FDA has increasingly used a complex, cutting-edge technology ... Put as simply as possible, whole genome sequencing is a ...
(Date:6/23/2016)... ... 2016 , ... Charm Sciences, Inc. is pleased to announce ... Research Institute approval 061601. , “This is another AOAC-RI approval of the Peel ... President of Regulatory and Industrial Affairs. “The Peel Plate methods perform comparably to ...
Breaking Biology Technology: